Natalizumab Induces Changes of Cerebrospinal Fluid Measures in Multiple Sclerosis

Background: There is a lack of knowledge about the evolution of cerebrospinal fluid (CSF) markers in multiple sclerosis (MS) patients undergoing natalizumab treatment. Aim: We aimed to evaluate the effect of natalizumab on basic inflammatory CSF and MRI measures. Methods: Together, 411 patients were...

Descripción completa

Detalles Bibliográficos
Autores principales: Ganapathy Subramanian, Ranjani, Horakova, Dana, Vaneckova, Manuela, Lorincz, Balazs, Krasensky, Jan, Kubala Havrdova, Eva, Uher, Tomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699923/
https://www.ncbi.nlm.nih.gov/pubmed/34943468
http://dx.doi.org/10.3390/diagnostics11122230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699923/
https://www.ncbi.nlm.nih.gov/pubmed/34943468
http://dx.doi.org/10.3390/diagnostics11122230

Ejemplares similares